A new study found no relationship between statins and an increased risk of breast cancer, in contrast to previous data suggesting otherwise. In addition, researchers found women who took hydrophobic statins, including Zocor, Mevacor and Lescol, had an 18% less chance of developing invasive breast cancer than women who did not take the drugs.

Related Summaries